Is plasma N-BNP a good indicator of the functional reserve of failing hearts? the FRESH-BNP study

European Journal of Heart Failure

Volumn 6, Issue 7, 2004, Pages 891-900

  Williams, Simon G ^a   Ng, Leong L ^b   O'Brien, Russell J ^b   Taylor, Steve ^c   Wright, D Jay ^a   Tan, Lip Bun ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Brain natriuretic peptide; Cardiac power output; Cardiac pump function; Chronic heart failure; Left ventricular ejection fraction; Peak oxygen consumption

Indexed keywords

NATRIURETIC FACTOR; OXYGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 8844263070     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.03.005     Document Type: Article

References (70)

1. Groenning B.A., Nilsson J.C., Sondergaard L., et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail. 3:2001;699-708
2. Stanek B., Frey B., Hulsmann M., et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol. 38:2001;436-442
3. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl J Med. 311:1984;819-823
4. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 82:1990;1730-1736
5. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with or without congestive heart failure: a study of the studies of left ventricular dysfunction (SOLVD). Circulation. 82:1990;1724-1729
6. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1349-1353
7. Cowie M.R., Mendez G.F. BNP and congestive heart failure. Prog Cardiovasc Dis. 44:2002;293-321
8. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 141:2001;367-374
9. Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin. 19:2001;557-571
10. Harrison A., Morrison L.K., Krishnaswamy P., et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 39:2002;131-138
11. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. New Engl J Med. 350:2004;655-663
12. Koglin J., Pehlivanli S., Schwaiblmair M., et al. Role of brain natriuretic peptide in risk stratification of patients with chronic heart failure. J Am Coll Cardiol. 38:2001;1934-1941
13. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 105:2002;2392-2397
14. McDonagh T.A., Cunningham A.D., Morrison C.E., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 86:2001;21-26
15. Hunt P.J., Yandle T.G., Nicholls M.G., Richards A.M., Espiner E.A. The amino-terminal portion of pro-brain natriuretic peptide (pro BNP) circulates in human plasma. Biochem Biophys Res Commun. 214:1995;1175-1183
16. Hunt P.J., Richards A.M., Nicholls M.G., et al. Immunoreactive amino-terminal portion of pro-brain natriuretic peptide (NT-pro BNP): a new marker of cardiac impairment. Clin Endocrinol. 47:1997;287-296
17. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929
18. Talwar S., Squire I.B., Davies J.E., Barnett D.B., Ng L.L. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J. 20:1999;1736-1744
19. Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic function. Eur Heart J. 21:2000;1514-1521
20. NICE/RCP Guideline Development and Consensus Reference Groups. Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. A clinical guideline for the NHS in England and Wales, 2003 (In press)
21. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left ventricular systolic dysfunction. Lancet. 351:1998;9-13
22. Steele I.C., McDowell G., Moore A., et al. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest. 27:1997;270-276
23. Friedl W., Mair J., Thomas S., Pichler M., Puschendorf B. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise. Clin Chim Acta. 281:1999;121-126
24. Bettencourt P., Ferreira A., Pardal-Oliveira N., et al. Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction. Clin Cardiol. 23:2000;921-927
25. Hammerer-Lercher A., Neubauer E., Muller S., et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta. 310:2001;193-197
26. Jourdain P., Funck F., Bellorini M., et al. Bedside B-type natriuretic peptide and functional capacity in chronic heart failure. Eur J Heart Fail. 5:2003;155-160
27. Benge W., Litchfield R.L., Marcus M.L. Exercise capacity in patients with severe left ventricular dysfunction. Circulation. 61:1980;955-959
28. Franciosa J., Park M., Levine T.B. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol. 47:1981;33-39
29. Tebbe U., Sauer G., Kreuzer H., Neuhaus K.L. Left ventricular contraction and relaxation in patients with congestive cardiomyopathy during exercise. Z Kardiol. 71:1982;406-412
30. Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 87:(Suppl. 6):1993;VI5-16
31. Carell E.S., Murali S., Schulman D.S., Estrada-Quintero T., Uretsky B.F. Maximal exercise tolerance in chronic congestive heart failure. Relationship to resting left ventricular function. Chest. 106:1994;1746-1752
32. Marmor A., Schneeweiss A. Prognostic value of non-invasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol. 29:1997;422-428
33. Cintron G., Johnson G., Francis G., Cobb F., Cohn J.N. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 87:(Suppl. 6):1993;VI17-23
34. Tan L.B. Cardiac pumping capability and prognosis in heart failure. Lancet. ii:1986;1360-1363
35. Tan L.B. Evaluation of cardiac dysfuncton, cardiac reserve and inotropic response. Postgrad Med J. 67:(Suppl. 1):1991;S10-20
36. Roul G., Moulichon M.E., Bareiss P., et al. Prognostic factors of chronic heart failure in NYHA class II or II: value of invasive exercise haemodynamic data. Eur Heart J. 16:1995;1387-1398
37. Williams S.G., Cooke G.A., Wright D.J., Parsons W.J., Riley R.L., Marshall P., et al. Peak exercise cardiac power output: a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J. 22:2001;1496-1503
38. Cotter G., Williams S.G., Vered Z., Tan L.B. The role of cardiac power in heart failure. Current Opin Cardiol. 18:2003;215-222
39. Luchner A., Muders F., Dietl O., et al. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res. 51:2001;601-607
40. Maeda K., Tsutamota T., Wada A., Hisanga T., Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 135:1998;825-832
41. Nakagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J Clin Invest. 96:1995;1280-1287
42. Kinnunen P., Vuolteenaho O., Ruskoaho R.H. Mechanisms of atrial and brain natriuretic release from rat ventricular myocardium, effect of stretching. Endocrinology. 132:1993;161-170
43. Beaver W.L., Wasserman K., Whipp B.J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 60:1986;2020-2027
44. Cohen-Solal A., Tabet J.Y., Logeart D., et al. A non-invasively determined surrogate of cardiac power (circulatory power) at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J. 23:2002;806-814
45. 2 by re-breathing. J Appl Physiol. 9:1956;25-29
46. Cooke G.A., Marshall P., Al-Timman J.K., Wright D.J., Riley R., Tan L.B. Physiological cardiac reserve; development of a non-invasive method and first estimates in man. Heart. 79:1998;289-294
47. 2 rise during rebreathing. J Appl Physiol. 13:1958;159-164
48. Ira S. Human physiology. 5th ed :1996;414-415 William C Brown Publishers, Iowa
49. Ng L.L., Loke I., O'Brien R.J., Squire L.B, Davies J.E. Plasma urotensin in human systolic heart failure. Circulation. 106:2002;2877-2880
50. Willenheimer R.B., Israelsson B.A., Cline C.M., Erhardt L.R. Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovasc J. 31:1997;9-16
51. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130
52. Yokoyama Y., Tanabe K., Yamada S., Itoh H. Changes in plasma level of brain natriuretic peptide during exercise in recovery phase of myocardial infarction and the clinical significance. J Cardiol. 27:1996;121-131
53. Kruger S., Graf J., Kunz D., et al. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 40:2002;718-722
54. Rocca H.P., Weilenmann D., Follath F., et al. Oxygen uptake kinetics during low level exercise in patients with heart failure: relation to neurohormones, peak oxygen consumption and clinical findings. Heart. 81:1999;121-127
55. Tjeerdsma G., de Boer R.A., Boomsma F., et al. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure. Int J Cardiol. 86:2002;143-149
56. Tan L.B. Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure. Cardiovasc Res. 21:1987;615-622
57. Tan L.B., Wright D.J., Marshall P., Riley R. Is exercise capacity a reliable indicator for diagnosis and treatment of heart failure? Int Proc J. 9:1997;13-29
58. Scharf C., Merz T., Kiowski W., et al. Non-invasive assessment of cardiac pumping capacity during exercise predicts prognosis in patients with congestive heart failure. Chest. 122:2002;1333-1339
59. Bettencourt P., Frioes F., Azevedo A., Dias P., Pimenta J., Rocha-Goncalves F., et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol. 93:2004;45-48
60. Francis G.S., Goldsmith S.R., Cohn J.N. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J. 104:1982;725-731
61. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril cardiac evaluation (TRACE) study group. N Engl J Med. 333:1995;1670-1676
62. ESC (European Society of Cardiology) Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22:2001;1527-1560
63. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 104:2001;2996-3007
64. SIGN (Scottish Intercollegiate Guidelines Network) Publication No 35. Diagnosis and Treatment of Heart Failure due to Left Ventricular Systolic Dysfunction. A National Clinical Guideline. 1999;Royal College of Physicians, Edinburgh, http://www.sign.ac.uk/pdf/sign35.pdf
65. Williams S.G., Currie P., Silas J.H. Open access echocardiography: a prospective audit of referral patterns from primary care. Int J Clin Pract. 57:2003;136-139
66. Maisel A.S., Krishnaswamy R., Richard M., Nowak R.M., Mccord J., Hollander J.E., et al. For the breathing not properly multinational study investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med. 347:2002;161-167
67. Hobbs F.D.R., Davis R.C., Roalfe A.K., et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. Br Med J. 324:2002;1498-1500
68. Sagnella G.A. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci. 95:1998;519-529
69. Myers J., Gullestad L. The role of exercise testing and gas-exchange measurement in the prognostic assessment of patients with heart failure. Curr Opin Cardiol. 13:1998;145-155
70. Bain R.J.I., Tan L.B., Murray R.G., Davies M.K., Littler W.A. The correlation of cardiac power output to exercise capacity in chronic heart failure. Eur J Appl Physiol. 61:1990;112-118